← Leaderboards
Ashley Levack
Loyola University Chicago
$190,775
Attributed
$381,549
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $217K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$381,549 · 1
By mechanism
R21$381,549 · 1
Top collaborators
- James B. Doub2 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Margot S. Damaser$9,022,301
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAnimal ModelAntibioticsAntibody FormationAreaBacteriaBacteriophagesBlood VesselsBoneBone ProsthesisChronicClinical TrialsClonalityComparative EfficacyComplexComplicationConfined SpacesDebridementEffective TherapyEfficacy EvaluationEnsureFailureFemurAdjuvant Therapy
Grant awards (2)
The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocols$164,540
R21 · FY2025 · AR · contact PI
The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocols$217,009
R21 · FY2024 · AR · contact PI